Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Oncotelic Therapeutics, Inc. | 258,171 | reported | 20 Jun 2018 | tx 4+570,929 |
| Avalo Therapeutics, Inc. | 241,833 | reported | 09 Apr 2020 | tx 13+892,310−20,901 |
| Unite Acquisition 1 Corp. | 192,231 | reported | 08 Sept 2025 | tx 1+192,231 |
| Chelsea Therapeutics International, Ltd. | 175,000 | reported | 25 Jan 2012 | tx 15+1,275,325−100,000 |
| DELCATH SYSTEMS, INC. | 100,000 | reported | 01 Feb 2019 | tx 1+100,000 |
| Athenex, Inc. | 30,000 | reported | 03 Aug 2021 | tx 10+505,310 |
| Cellectar Biosciences, Inc. | 13,300 | reported | 20 Aug 2014 | tx 2+26,600 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 Sept 2025 | GRANT_AWARD | Unite Acquisition 1 Corp. | 192,231 | 0.00 USD | deriv |
| 03 Aug 2021 | GRANT_AWARD | Athenex, Inc. | 30,000 | 0.00 USD | deriv |
| 03 Aug 2021 | GRANT_AWARD | Athenex, Inc. | 30,000 | 0.00 USD | deriv |
| 05 Jun 2020 | GRANT_AWARD | Athenex, Inc. | 60,000 | 0.00 USD | deriv |
| 09 Apr 2020 | TAX_WITHHOLDING | Avalo Therapeutics, Inc. | 20,901 | 2.57 USD | |
| 27 Aug 2019 | PURCHASE | Avalo Therapeutics, Inc. | 6,734 | 2.98 USD | |
| 28 Jun 2019 | GRANT_AWARD | Avalo Therapeutics, Inc. | 117 | 0.00 USD | deriv |
| 24 May 2019 | GRANT_AWARD | Avalo Therapeutics, Inc. | 250,000 | 0.00 USD | |
| 24 May 2019 | GRANT_AWARD | Avalo Therapeutics, Inc. | 300,000 | 0.00 USD | deriv |
| 14 May 2019 | PURCHASE | Avalo Therapeutics, Inc. | 6,000 | 5.06 USD | |
| 16 Apr 2019 | GRANT_AWARD | Athenex, Inc. | 1,402 | 0.00 USD | |
| 15 Apr 2019 | GRANT_AWARD | Avalo Therapeutics, Inc. | 300,000 | 0.00 USD | deriv |
| 29 Mar 2019 | GRANT_AWARD | Avalo Therapeutics, Inc. | 882 | 0.00 USD | deriv |
| 27 Mar 2018 | GRANT_AWARD | Athenex, Inc. | 60,000 | 0.00 USD | deriv |
| 28 Feb 2019 | GRANT_AWARD | Athenex, Inc. | 60,000 | 0.00 USD | deriv |
| 01 Feb 2019 | GRANT_AWARD | DELCATH SYSTEMS, INC. | 100,000 | 0.00 USD | deriv |
| 31 Dec 2018 | GRANT_AWARD | Avalo Therapeutics, Inc. | 1,504 | 0.00 USD | deriv |
| 14 Nov 2018 | PURCHASE | Athenex, Inc. | 2,908 | 10.26 USD | first after silence |
| 28 Sept 2018 | GRANT_AWARD | Avalo Therapeutics, Inc. | 990 | 0.00 USD | deriv |
| 29 Jun 2018 | GRANT_AWARD | Avalo Therapeutics, Inc. | 1,012 | 4.34 USD | deriv |
| 20 Jun 2018 | GRANT_AWARD | Oncotelic Therapeutics, Inc. | 258,171 | 0.00 USD | deriv |
| 15 May 2018 | GRANT_AWARD | Avalo Therapeutics, Inc. | 8,357 | 0.00 USD | deriv |
| 06 Apr 2018 | GRANT_AWARD | Avalo Therapeutics, Inc. | 16,714 | 0.00 USD | deriv |
| 19 Jun 2017 | GRANT_AWARD | Athenex, Inc. | 130,000 | 0.00 USD | deriv |
| 09 Jun 2017 | GRANT_AWARD | Oncotelic Therapeutics, Inc. | 121,483 | 0.00 USD | deriv |
4 purchases reported after at least 12 months of silence — most recent on 14 Nov 2018.